Mortality ( · adult participants (> 16 years of age) undergoing intestinal resection due to Crohn's disease
1 finding from 1 review
Mortality within the longest · Children having heart surgery with cardiopulmonary bypass
Glucocorticoid showed no clear difference in all‐cause mortality at longest compared with placebo (moderate certainty).
1 finding from 1 review
Mortality within the longest · adults undergoing non‐cardiac surgery
Continuation showed no clear difference in all‐cause mortality (at longest compared with discontinuation of antiplatelet therapy (low certainty).
1 finding from 1 review
All‐cause mortality up to 30 days · people aged 18 and over undergoing vascular surgery
1 finding from 1 review
All‐cause mortality up to 30 days · people aged 18 and over undergoing vascular surgery
It is very uncertain whether summary of findings: Fibrin sealant changes all‐cause mortality up to 30 days compared with usual care (very low certainty).
1 finding from 1 review
Mortality during hospitalisation ( · adults with dementia following hip fracture surgery
It is very uncertain whether interdisciplinary enhanced rehabilitation (inpatient rehabilitation) changes mortality (during hospitalisation) compared with conventional rehabilitation (very low certainty).
1 finding from 1 review
Mortality within the longest · adult surgical patients with the need for cardiopulmonary bypass‐dependent heart surgery
It is very uncertain whether pulmonary artery perfusion with blood changes all‐cause mortality within longest compared with no perfusion during cardiopulmonary bypass (very low certainty).
1 finding from 1 review
In‐hospital postoperative mortality · Children having heart surgery with cardiopulmonary bypass
Glucocorticoid showed no clear difference in in‐hospital postoperative mortality compared with placebo (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · Children having heart surgery with cardiopulmonary bypass
Glucocorticoid showed no clear difference in cardiovascular mortality at longest compared with placebo (moderate certainty).
1 finding from 1 review
Mortality within the longest · adults receiving intravenous fluids while undergoing major non‐cardiac surgery
It is very uncertain whether perioperative restrictive fluid therapy changes all‐cause mortality (during longest compared with goal‐directed fluid therapy (very low certainty).
1 finding from 1 review
All‐cause mortality rate at 30 days · adults having abdominal surgery
Epidural analgesia showed no clear difference in all‐cause mortality rate at 30 days compared with intravenous patient‐controlled analgesia (low certainty).
1 finding from 1 review
All‐cause mortality (up to 30 days) · adults undergoing non‐cardiac surgery
Continuation showed no clear difference in all‐cause mortality (up to 30 days) compared with discontinuation of antiplatelet therapy (low certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality (within 30 days) · adults undergoing cardiac surgery under general anaesthesia
The intervention showed no clear difference in all‐cause mortality (within 30 days) (low certainty).
1 finding from 1 review
All‐cause mortality · Patients with hip fracture repair
It is very uncertain whether neuraxial block changes mortality compared with general anaesthesia (very low certainty).
1 finding from 1 review
Short‐term mortality (up to 30 days) · Neonates, children and adults undergoing cardiovascular surgery
1 finding from 1 review
All‐cause mortality · participants with obesity
1 finding from 1 review
All‐cause mortality · participants with obesity
1 finding from 1 review
All‐cause mortality · participants with obesity
1 finding from 1 review
All‐cause mortality · participants with obesity
1 finding from 1 review
All‐cause mortality · participants with obesity
The review found no eligible studies for this question.
1 finding from 1 review